HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Jamin Selected Research

NSC-134754

5/2012The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Jamin Research Topics

Disease

5Neoplasms (Cancer)
05/2020 - 05/2012
3Necrosis
04/2015 - 09/2013
2Neuroblastoma
05/2020 - 01/2016
2Carcinoma (Carcinomatosis)
04/2015 - 09/2013
2Hypoxia (Hypoxemia)
06/2012 - 05/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016
1Colorectal Neoplasms (Colorectal Cancer)
04/2014
1Melanoma (Melanoma, Malignant)
09/2013
1Adenocarcinoma
06/2012
1Prostatic Neoplasms (Prostate Cancer)
05/2012

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
04/2014 - 06/2012
1pifithrinIBA
05/2020
1Telomerase (Telomerase Reverse Transcriptase)IBA
05/2020
1alpha-2'-deoxythioguanosineIBA
05/2020
1ceralasertibIBA
05/2020
1lorlatinibIBA
01/2016
1CrizotinibIBA
01/2016
1Anaplastic Lymphoma KinaseIBA
01/2016
1Phosphotransferases (Kinase)IBA
01/2016
1Irinotecan (Camptosar)FDA LinkGeneric
04/2015
1birinapantIBA
04/2015
1Phosphates (Orthophosphate)IBA
04/2014
1N-acetylcolchinolIBA
04/2014
1N-acetylcochinol-O-phosphateIBA
04/2014
1AZD 6244IBA
09/2013
1Caspase 3 (Caspase-3)IBA
09/2013
1vandetanib (ZD6474)IBA
06/2012
1NSC-134754IBA
05/2012
1Glucose (Dextrose)FDA LinkGeneric
05/2012

Therapy/Procedure

2Therapeutics
05/2020 - 06/2012
1Aftercare (After-Treatment)
04/2014